Skip to main content
. 2019 Dec 19;7:e8277. doi: 10.7717/peerj.8277

Figure 7. Expression distribution of REs selected as potential biomarkers for LUAD and SCLC, plotted using the same criteria as described in Fig. 3.

Figure 7

(A) The 11 REs of the primary set of biomarker candidates in LUAD and SCLC. (B) The 10 REs of the suitable set (namely, those of A without MER65-Int) of biomarker candidates in the seven new patients with LUAD studied in Arroyo et al. (2018).